Nusinoff-Lehrman S - Search Results

1

Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.

Chaisson RE, Leuther MD, Allain JP, Nusinoff-Lehrman S, Boone GS, Feigal D, Volberding P. Chaisson RE, et al. Among authors: nusinoff lehrman s. Arch Intern Med. 1988 Oct;148(10):2151-3. Arch Intern Med. 1988. PMID: 3263098 Clinical Trial.

2

HIV-1 inhibition by azidothymidine in a concurrently randomized placebo-controlled trail.

Parks WP, Parks ES, Fischl MA, Leuther MD, Allain JP, Nusinoff-Lehrman S, Barry DW, Makuch RW. Parks WP, et al. Among authors: nusinoff lehrman s. J Acquir Immune Defic Syndr (1988). 1988;1(2):125-30. J Acquir Immune Defic Syndr (1988). 1988. PMID: 3145972 Clinical Trial.

3

Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals.

Hollander H, Lifson AR, Maha M, Blum R, Rutherford GW, Nusinoff-Lehrman S. Hollander H, et al. Among authors: nusinoff lehrman s. Am J Med. 1989 Dec;87(6):628-32. doi: 10.1016/s0002-9343(89)80394-8. Am J Med. 1989. PMID: 2574006

4

Survival experience among patients with AIDS receiving zidovudine. Follow-up of patients in a compassionate plea program.

Creagh-Kirk T, Doi P, Andrews E, Nusinoff-Lehrman S, Tilson H, Hoth D, Barry DW. Creagh-Kirk T, et al. Among authors: nusinoff lehrman s. JAMA. 1988 Nov 25;260(20):3009-15. JAMA. 1988. PMID: 3263514

5

Viral resistance, clinical experience.

Barry DW, Nusinoff-Lehrman S, Ellis MN, Biron KK, Furman PA. Barry DW, et al. Scand J Infect Dis Suppl. 1985;47:155-64. Scand J Infect Dis Suppl. 1985. PMID: 3006230

6

Studying treatments for AIDS: new challenges for clinical trials--a panel discussion at the 1990 annual meeting of the Society for Clinical Trials.

Ellenberg SS, Cooper E, Eigo J, Finkelstein DM, Hoth DF, Nusinoff-Lehrman S, Sacks H. Ellenberg SS, et al. Among authors: nusinoff lehrman s. Control Clin Trials. 1992 Aug;13(4):272-92. doi: 10.1016/0197-2456(92)90011-n. Control Clin Trials. 1992. PMID: 1330433 No abstract available.

7

Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromes.

Sacks SL, Fox R, Levendusky P, Stiver HG, Roland S, Nusinoff-Lehrman S, Keeney R. Sacks SL, et al. Among authors: nusinoff lehrman s. Sex Transm Dis. 1988 Jan-Mar;15(1):58-62. doi: 10.1097/00007435-198801000-00013. Sex Transm Dis. 1988. PMID: 3282336 Clinical Trial.

8

Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.

Kit S, Sheppard M, Ichimura H, Nusinoff-Lehrman S, Ellis MN, Fyfe JA, Otsuka H. Kit S, et al. Among authors: nusinoff lehrman s. Antimicrob Agents Chemother. 1987 Oct;31(10):1483-90. doi: 10.1128/AAC.31.10.1483. Antimicrob Agents Chemother. 1987. PMID: 2829709 Free PMC article.

9

Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection.

Rabalais GP, Nusinoff-Lehrman S, Arvin AM, Levin MJ. Rabalais GP, et al. Among authors: nusinoff lehrman s. Pediatr Infect Dis J. 1989 Apr;8(4):221-3. Pediatr Infect Dis J. 1989. PMID: 2541398

10

NIH Conference. Herpes simplex virus infection: biology, treatment, and prevention.

Straus SE, Rooney JF, Sever JL, Seidlin M, Nusinoff-Lehrman S, Cremer K. Straus SE, et al. Among authors: nusinoff lehrman s. Ann Intern Med. 1985 Sep;103(3):404-19. doi: 10.7326/0003-4819-103-3-404. Ann Intern Med. 1985. PMID: 2411179 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters